<SEC-DOCUMENT>0001193125-19-286603-index.html : 20191107
<SEC-HEADER>0001193125-19-286603.hdr.sgml : 20191107
<ACCEPTANCE-DATETIME>20191107071002
ACCESSION NUMBER:		0001193125-19-286603
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20191107
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20191107
DATE AS OF CHANGE:		20191107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			X4 Pharmaceuticals, Inc
		CENTRAL INDEX KEY:			0001501697
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				273181608
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38295
		FILM NUMBER:		191198111

	BUSINESS ADDRESS:	
		STREET 1:		955 MASSACHUSETTS AVENUE
		STREET 2:		4TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-529-8300

	MAIL ADDRESS:	
		STREET 1:		955 MASSACHUSETTS AVENUE
		STREET 2:		4TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Arsanis, Inc.
		DATE OF NAME CHANGE:	20100920
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d828896d8k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: d828896d8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d828896dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: d828896dex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g828896g1106070928848.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: g828896g1106070928848.jpg

</DOCUMENT>
</SEC-DOCUMENT>